Abstract:Parkinson’s disease (PD) is a multifaceted progressive neurodegenerative disease that includes a broad range of motor and non-motor symptoms (NMS). Autonomic nervous system (ANS) dysfunction is associated with a number of common NMS in PD that exert a profound impact on quality of life and increase the risk of mortality. ANS dysfunction, which likely precedes the onset of motor symptoms, includes changes in heart rate variability (HRV) that reflect pathological adjustments in the balance between sympathetic (SNS) and parasympathetic (PNS; vagal) influences on heart rate control. While the primary neuropathology of PD is related to the loss of dopamine neurons in the nigrostriatal pathway, serotonergic (5-HT) dysfunction also appears to play a role in the development of some motor and NMS and complications in PD. 5-HT is also known to play a critical role in cardiovascular (cardiac) regulation; thus, autonomic dysfunction in PD may be further complicated by 5-HT dysfunction. To begin to address this possibility, we investigated HRV quantified from 5-min segments of continuously recorded ECG activity before and after acute systemic administration of the 5-HT 1A receptor agonist 8-OH-DPAT (DPAT) in urethane-anesthetized adult female rats at 2-weeks after unilateral injection of the neurotoxin 6-OHDA (n=11) or vehicle (VEH; n=7) directly into the substantia nigra (SN). HRV measures evaluated included standard deviation (SD) of R-R intervals (SDRR) and root mean square of successive differences in R-R (RMSSD) as time-domain measures; absolute (abs) and normalized (nu) low-frequency (LF: 0.2-0.75 Hz) and high-frequency (HF: 0.75-3.0 Hz) spectral power and the LF/HF ratio as frequency domain measures; and Poincaré plot SD perpendicular to (SD1) and along (SD2) the line of identity and the SD1/SD2 ratio as non-linear measures. For these analyses, SDRR, LF, and SD2 were considered indices of mixed cardiac SNS and PNS activity; RMSSD, HF, and SD1 were considered indices of PNS activity; and LF/HF and SD1/SD2 were considered indices of sympatho-vagal balance. Before DPAT (compared to VEH-injected rats), 6-OHDA-injected rats exhibited slightly but not significantly higher HR and lower SDRR, RMSSD, abs and nu LF power, abs HF power, LF/HF ratio, SD1, and SD2, but the R-R interval, nu HF power, and SD1/SD2 ratio were similar between the groups. Following DPAT administration, both 6-OHDA- and VEH-injected rats exhibited significantly reduced HR by ~15% and increased R-R intervals by 20%. In 6-OHDA-injected rats, DPAT also increased SDRR, RMSSD, abs HF power, SD1, and the SD1/SD2 ratio but significantly reduced nu HF power; similar trends were noted in VEH-injected rats. These data demonstrate that while most HRV measures are minimally altered under baseline conditions, 5-HT 1A receptor activation can significantly alter autonomic balance and HRV metrics (especially measures associated with PNS activity) in the SN 6-OHDA-induced lesion rat model of PD. NIH NS101737; Thomas Hartman Center for Parkinson's Disease Research at Stony Brook University This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Alterations in 5-HT<sub>2A</sub>receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

Alterations of NMDA Receptor Binding in Various Brain Regions among 6-Hydroxydopamine-induced Parkinsonian Rats

Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats.

Unilateral Lesion of the Nigrostriatal Pathway Induces an Increase of Neuronal Firing of the Midbrain Raphe Nuclei 5-HT Neurons and a Decrease of Their Response to 5-HT(1A) Receptor Stimulation in the Rat.

Changes in the Firing Activity of Serotonergic Neurons in the Dorsal Raphe Nucleus in a Rat Model of Parkinson's Disease.

Activation and Blockade of Serotonin(6) Receptors in the Dorsal Hippocampus Enhance T Maze and Hole-Board Performance in A Unilateral 6-Hydroxydopamine Rat Model of Parkinson'S Disease

In Vivo Effects of Activation and Blockade of 5-HT(2A/2C) Receptors in the Firing Activity of Pyramidal Neurons of Medial Prefrontal Cortex in a Rodent Model of Parkinson's Disease.

Serotonin (5-HT)-1A receptor activation alters heart rate variability (HRV) in SN 6-OHDA-induced rat model of Parkinson's Disease

Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Neuronal activity and expression of 5-HT1A receptor of medial prefrontal cortex in rats model with parkinson's disease

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia

Serotonin1A Receptors in the Dorsal Hippocampus Regulate Working Memory and Long-Term Habituation in the Hemiparkinsonian Rats.

Effects of 5-HT1A receptor in hippocampal dentate gyrus on anxiety-related behavior of adult rats with Parkinson's disease

Serotonin7 Receptors in the Lateral Habenular Nucleus Regulate Depressive-Like Behaviors in the Hemiparkinsonian Rats

Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study

Activation and blockade of 5-HT<sub>6</sub> receptor in the medial septum-diagonal band recover working memory in the hemiparkinsonian rats

The Selective 5-HT1A Receptor Antagonist WAY-100635 Inhibits Neuronal Activity of the Ventromedial Prefrontal Cortex in a Rodent Model of Parkinson’s Disease

Activation and Blockade of Serotonin-4 Receptors in the Lateral Habenula Produce Antidepressant Effects in the Hemiparkinsonian Rat.

In Vivo Effect of a 5-HT7 Receptor Agonist on 5-HT Neurons and GABA Interneurons in the Dorsal Raphe Nuclei of Sham and PD Rats